BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1340136)

  • 21. The putative tumor suppressor gene on chromosome 5q for hepatocellular carcinoma is distinct from the MCC and APC genes.
    Ding SF; Delhanty JD; Dooley JS; Bowles L; Wood CB; Habib NA
    Cancer Detect Prev; 1993; 17(3):405-9. PubMed ID: 8402727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibition effect of p53 antisense RNA on malignant phenotype of colorectal cancer cells].
    Cao J; Teng L; Cai X
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):123-6. PubMed ID: 10743076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6.
    Monti L; Cinquetti R; Guffanti A; Nicassio F; Cremona M; Lavorgna G; Bianchi F; Vignati F; Cittaro D; Taramelli R; Acquati F
    Int J Oncol; 2009 Apr; 34(4):1099-108. PubMed ID: 19287968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.
    Yu W; Gius D; Onyango P; Muldoon-Jacobs K; Karp J; Feinberg AP; Cui H
    Nature; 2008 Jan; 451(7175):202-6. PubMed ID: 18185590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer.
    Gustafson CE; Wilson PJ; Lukeis R; Baker E; Woollatt E; Annab L; Hawke L; Barrett JC; Chenevix-Trench G
    Cancer Res; 1996 Nov; 56(22):5238-45. PubMed ID: 8912863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the FHIT gene in colorectal cancers.
    Thiagalingam S; Lisitsyn NA; Hamaguchi M; Wigler MH; Willson JK; Markowitz SD; Leach FS; Kinzler KW; Vogelstein B
    Cancer Res; 1996 Jul; 56(13):2936-9. PubMed ID: 8674044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense strategies come of age. Antisense strategies sponsored by the New York Academy of Sciences, Philadelphia, PA, USA, January 12-15, 1992.
    Denhardt DT
    New Biol; 1992 May; 4(5):473-81. PubMed ID: 1515412
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.
    Rintala-Maki ND; Sutherland LC
    Gene; 2009 Sep; 445(1-2):7-16. PubMed ID: 19559772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.
    Thiagalingam S; Lengauer C; Leach FS; Schutte M; Hahn SA; Overhauser J; Willson JK; Markowitz S; Hamilton SR; Kern SE; Kinzler KW; Vogelstein B
    Nat Genet; 1996 Jul; 13(3):343-6. PubMed ID: 8673134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic steps in colorectal cancer].
    Ichii S; Utsunomiya J
    Nihon Rinsho; 1996 Apr; 54(4):1072-7. PubMed ID: 8920676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of critical genetic lesions in human colorectal carcinoma xenografts.
    McQueen HA; Wyllie AH; Piris J; Foster E; Bird CC
    Br J Cancer; 1991 Jan; 63(1):94-6. PubMed ID: 1989671
    [No Abstract]   [Full Text] [Related]  

  • 32. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
    Gao X; Honn KV; Grignon D; Sakr W; Chen YQ
    Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biology and colorectal cancer: genetic alterations, inherited syndromes, and applications to colon cancer screening.
    O'Brien BL; DiPalma JA
    Dig Dis; 1995; 13(3):182-9. PubMed ID: 8548981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic changes in the genesis of gastrointestinal carcinoma.
    Blin N; Seitz G; Theisinger B; Schüder G; Welter C
    Endoscopy; 1992 Nov; 24(9):782-4. PubMed ID: 1468397
    [No Abstract]   [Full Text] [Related]  

  • 35. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
    Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
    Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antisense strategies come of age].
    Yokoyama K
    Tanpakushitsu Kakusan Koso; 1993 Mar; 38(4):753-65. PubMed ID: 8475331
    [No Abstract]   [Full Text] [Related]  

  • 37. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
    Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.
    Cawkwell L; Lewis FA; Quirke P
    Br J Cancer; 1994 Nov; 70(5):813-8. PubMed ID: 7947085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer.
    Park WS; Park JY; Oh RR; Yoo NJ; Lee SH; Shin MS; Lee HK; Han S; Yoon SK; Kim SY; Choi C; Kim PJ; Oh ST; Lee JY
    Cancer Res; 2000 Jan; 60(1):70-3. PubMed ID: 10646855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No SMAD4 hypermethylation in colorectal cancer.
    Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
    Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.